Oncotarget: Outlining Innovations And Research In Oncology

The field of cancer research is extremely expansive, with innovations taking place every single day. With the field being this vast, it becomes difficult for doctors from all over to be connected with each other to share the findings that the make and the innovations that come into place. The need for a newsletter that helps doctors to connect with each other and share their views and opinions and research was prominent, which is why Mikhail Blagosklonny tried to fill this void with the publication of Oncotarget. Oncotarget functions as a peer to peer review newsletter, which is open to doctors and those who are interested in the field of oncology from around the world. Doctors who are making advances in the area of oncology are encouraged to send in their articles discussing their discoveries and thoughts on the latest innovations in the field.

The newsletter has managed to bridge the gap between doctors and oncologists from all over the world, offering them a glance into how doctors treat their patients in different countries. The newsletter takes pride in being entirely global, with contributors giving different perspectives on how patients who are diagnosed with cancer are being treated in their countries.The newsletter was founded by Mikhail Blagosklonny in 2010. Since its first publication, the readership and contributors to the newsletter have grown significantly. When a doctor or researcher sends in their articles to be published through Oncotarget, they are reviewed by Mikhail Blagosklonny and his team of trusted associates who have a good amount of experience in the field. The articles are chosen based on their originality, and whether or not they can be a significant contribution to the field.

The articles go way beyond the conventional topics that oncological research journals cover so that they can truly expand on the subject in the best way to treat cancer. By doing this, the newsletter puts out only that content that is one of a kind and talks about the latest happenings in the field.Oncotarget does not have a restriction and can be viewed by literally anyone who is interested in the field. The newsletter is published weekly, with new topics and new innovations being featured every week. The ultimate aim of the publication is to facilitate the spread of knowledge among doctors so that the entire oncological community can grow and develop as one cohesive unit for the betterment of society and the people.

What no one tells you about Oncotarget

Oncotarget is a medical and peer-reviewed journal published every week. It covers main topics such research on oncology. Oncology is the branch of medicine specializing in the diagnosis, preventing and treating cancer. Oncotarget was founded in the year 2010, and it is currently under Impact Journals which publishes it.The chief editors of this popular medical journal are Mikhail Blagosklonny (a known scientist who dedicates his time in studying cancer and aging) and Andrei V. Gudkov.Blagosklonny has been very instrumental in research on cancer where he has a personal impact factor of 83 gained through his authorship. He has written over 270 papers which have been published in various peer-reviewed journals.Oncotarget has a journal impact factor (JIF) of 5.168 as by the year 2016/2017. T

his skyrocketing popularity is attributed to its comprehensive offers in insightful, peer-reviewed, and punctual help that goes to authors to aid them in increasing the impact of their research findings.Besides oncology, Oncotarget accepts papers in other topics that include but not limited to Endocrinology, Cardiology, Neuroscience, Pharmacology, metabolism, and Cell Biology.The site seeks to publish outstanding research that will aid in developing best approaches towards cancer. But due to tumor growth complexity, Oncotarget decided to include the above publications to smoothen the research.And to emphasize on the quality and integrity of the research, Oncotarget’s editors ensure that they are in line with the Committee on Publications Ethics (COPE) laws. Authors are advised to read and understand the requirements before submitting their papers.

This information is available on the journal’s official website.Oncotarget can be found on social networks including Facebook ( Oncotarget) and has its archives accessible to the public. Anyone is free to use the research to further their knowledge. Searching for such information is easier, all you can do is type your question on the search bar, and within few seconds, you’ll be done.Oncotarget recently published research that e-cigarettes are as harmful as the tobacco especially to the gum tissues. The research was conducted by Irfan Rahman, professor of Environmental Medicine at UR School of Medicine.The research concluded that the vapors from the e-cigars cause the cells in the gums to release inflammatory proteins, increasing stress inside the cells and might end up causing other oral diseases. Besides this critical publication, Oncotarget has also published a research paper that highlighted the progress taken by researchers towards finding the cure to gastric cancer.

It is People Like Eric Lefkofsky who will Improve the Industry the Most in the Coming Years

Changes in Health

There are a lot of changes taking place in the healthcare industry today. With more technology than ever before, many people are starting to improve their overall quality of life greatly. Now is the time to invest money into this area to save lives in the future. One of the best new innovations in the industry is the rise of preventative medicine. This is where we can now prevent issues before they come up in the body. It requires a lot of technology to do this, but it is a great way to prevent illness and death later on in life.

Cost of Care

The biggest issue facing the medical industry today is the cost of care. Few people can afford to pay for a health issue if it comes up in their life. With that being said, health insurance costs are starting to increase rapidly as well. The middle class is being hurt in both areas financially.

The good news is that health treatment technology should lower the cost of care over a long period of time. With all of the changes that are going on, now is the time for people to take control of their health again. A lot of people struggle with their health today because they have poor lifestyle habits to learn more: https://www.bizjournals.com/chicago/news/2017/04/12/groupon-co-founder-moves-to-help-youth-access-art.html click here.

Eric Lefkofsky

One of the leaders in the field of health about Eric Lefkofsky. He is passionate about the work that he does, and he wants to take the industry to a new level. He sees all of the opportunities that are available within this field to drive growth and innovation in the future.

With all of the changes that are happening in healthcare, it is vital for business leaders to have a vision of the future. Many business leaders are only concentrating on driving profits for the next quarter. It is people like Eric Lefkofsky who will improve the industry the most in the coming years.

He has a passion for helping others that few other people have. Not only that, but he is more interested in saving lives than making money.